MetaCap

KORU Medical Systems (KRMD) vs Neuronetics (STIM)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Neuronetics (STIM) has outperformed KORU Medical Systems (KRMD) over the past year, losing 4.6% versus a loss of 33.3%. Over five years, KRMD leads with a -12.6% price change compared with -69.7% for STIM. KORU Medical Systems is the larger company by market cap ($138.4 million vs $120.6 million), about 1.1 times the size, while Neuronetics is growing revenue faster (+99.2% vs +22.2%).

KORU Medical Systems converts more of its revenue into profit, with a net margin of -6.4% versus -26.1%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

KRMD-33.26%STIM-4.58%
+161%+57%-48%
Nov 21, 20251 yearNov 20, 2026
KRMD-6.18%STIM-68.75%
+92%+0%-91%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

KRMD versus STIM key metrics
MetricKRMDSTIM
Share price$3.19$1.25
Market cap$138.37M$120.60M
1-day change-7.27%+0.81%
YTD return-45.09%-9.42%
1-year return-33.26%-4.58%
5-year return-12.60%-69.66%
Forward P/E45.57—
EPS (TTM)$-0.02$-0.32
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$41.13M$149.16M
Revenue growth (YoY)+22.23%+99.17%
Net income (latest FY)$-2.64M$-39.00M
Gross margin62.26%48.48%
Operating margin-7.23%-21.08%
Net margin-6.41%-26.15%
52-week high$6.61$3.44
52-week low$2.86$0.80
Distance from 52-week high-51.73%-63.66%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+92.16%+380.00%
Average volume223.45K1.76M
Shares outstanding43.38M96.48M
Employees73658
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • STIM has outperformed KRMD by 28.7 percentage points over the past year.
  • KORU Medical Systems is more profitable, keeping -6.4 cents of every revenue dollar as net income versus -26.1 cents for Neuronetics.
  • Neuronetics grew revenue faster in its latest fiscal year (+99.17% vs +22.23%).

About KORU Medical Systems

KRMD stock →

KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally.

Health Care · Medical/Dental Instruments · 73 employees

About Neuronetics

STIM stock →

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally.

Health Care · Medical/Dental Instruments · 658 employees

KRMD vs STIM FAQ

Which is bigger, KORU Medical Systems or Neuronetics?

KORU Medical Systems (KRMD) is larger, with a market capitalization of $138.37M compared with $120.60M for Neuronetics (STIM).

Which stock has performed better over the past year, KRMD or STIM?

STIM returned -4.58% over the past 12 months, compared with -33.26% for KRMD (price return, excluding dividends). Past performance does not predict future results.

Are KORU Medical Systems and Neuronetics in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons